Top Medical News
8 hours ago
Researchers have recently developed and validated a prediction rule to identify patients with moderate-to-severe psoriasis who are not likely to respond adequately to methotrexate, reports a study. The rule indicates that 4 weeks of methotrexate may be enough to predict long-term response with limited safety risk.
13 Nov 2017
Family history of melanoma and CDKN2A mutation status significantly affect the risks of developing subsequent melanomas and other cancers and survival outcomes in patients with multiple primary melanomas (MPMs), a recent study has shown.
12 Nov 2017
Active and passive smoking are associated with atopic dermatitis, a new study from Korea reveals.
12 Nov 2017
Targeted anticancer therapies are associated with a significant risk of developing pigmentary changes during treatment, a recent study has found.
Dr. Priscilla Wong, Dr. Lydia Tam, Prof. LS Tam, 10 Nov 2017
This case report highlights that psoriatic arthritis is a heterogenous disease affecting multiple disease domains, and effective treatment requires thorough assessment of each of these different domains.
Stephen Padilla, 08 Nov 2017
IncobotulinumtoxinA is a fast-acting regimen for the treatment of glabellar frown lines (GFLs), with visible improvements by day 4 and patients expressing satisfaction with their treatment after 2 days, according to a Singapore study.
02 Nov 2017
Treatment with biologic agents appears to increase the rate of skin and soft tissue infections among patients with psoriasis, reports a recent study. In addition, a signal exists suggesting a heightened risk for meningitis.
Special Reports
17 Aug 2017
The prevalence of atopic dermatitis (AD) in industrialized countries has increased exponentially over the past three decades, currently affecting 15 to 30% of children and up to 10% of adults.1 At the recent official launch event of pimecrolimus (Elidel®, Meda Healthcare Sdn. Bhd.) held at Le Méridien Kuala Lumpur, Professor Thomas Luger provided insights on the pathophysiology of AD and the role of topical calcineurin inhibitors (TCIs) in the management of AD. 
12 Apr 2017
CANESTEN HC – Clotrimazole 1% w/w and hydrocortisone 1% w/w cream – Bayer
09 Dec 2016
All patients with acne are potentially at risk of scarring. Professor Goh Chee Leok addresses this issue by focussing on preventing the development of scars in his talk at the 41st Annual Meeting of the Dermatological Society of Malaysia held in Kuching, Sarawak.
28 Nov 2016
During the 41st Annual Dermatology Conference held in Kuching, Sarawak, Professor Steven R. Feldman updated the participants on the latest in topical treatment of psoriasis. Highlights from the presentation are summarized below.
11 Nov 2016
At the 7th Galderma Skin Day, leading dermatologists, Dr Najeeb Ahmad Mohd Safdar of Hospital Tuanku Ja’afar, Seremban and Dr Derrick Aw of the National University Hospital, Singapore, presented on managing atopic dermatitis and hand eczema, with a special focus on Cetaphil® Restoraderm (Galderma) and the newly launched Nutraplus® (Galderma).
08 Nov 2016
At the 7th Galderma Skin Day, renowned dermatologists, Dr Derrick Aw of the National University Hospital, Singapore and Dr Chan Lee Chin of Penang Hospital, shared practice pearls on managing melasma and acne.
Dr. Ch’ng Chin Chwen, Prof. Maria Teresita Gabriel, 17 Oct 2016
A 42-year-old Pakistani female consulted for spontaneously occurring generalized wheals of 6 months duration. She noticed that the wheals mostly appeared on her upper body and were erythematous, painful, pruritic, and unsightly.